AIDS and the skin: Parasitic diseases

Clinics in Dermatology

Volumn 18, Issue 4, 2000, Pages 433-439

  Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIPARASITIC AGENT; IVERMECTIN; KETOCONAZOLE; PAROMOMYCIN; PENTAMIDINE; PERMETHRIN; PYRIMETHAMINE; STIBOGLUCONATE SODIUM; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; LEISHMANIASIS; PARASITOSIS; PRIORITY JOURNAL; REVIEW; SCABIES; SKIN INFECTION; SKIN LEISHMANIASIS; TOXOPLASMOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMAN; LEISHMANIASIS; SCABIES; SKIN DISEASES, PARASITIC; TOXOPLASMOSIS;

EID: 0033833619     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00138-8     Document Type: Review

References (63)

1. Desjeux P. Leishmaniasis Public health aspects and control . Clin Dermatol. 14:1996;417-424.
2. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996;257-72.
3. Alvar J., Canavate C., Gutierrez-Solar B., et al. Leishmania and human immunodeficiency virus coinfection The first 10 years . Clin Microbiol Rev. 10:1997;298-319.
4. Cenini P., Berhe N., Hailu A., et al. Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis. J Infect Dis. 169:1994;707-708.
5. Alvar J. Leishmaniasis and AIDS co-infection. The Spanish example. Parasitol Today. 10:1994;160-163.
6. Gradoni L., Scalone A., Gramiccia M. HIV-Leishmania co-infections in Italy Serological data as indication of the sequence of acquisition of the two infections . Trans R Soc Trop Med Hyg. 87:1993;94-96.
7. Control of the leishmaniases. Report of a WHO Expert Committee. Technical Report Series, 1990;793. Geneva: WHO.
8. Ashford R.W., Desjeux P., De Raadt P. Estimation of population at risk of infection with leishmaniasis. Parasitol Today. 8:1991;104-105.
9. Desjeux P. Information on the epidemiology and control of the leishmaniases by country or territory. WHO/Leish/91.30. Geneva: CTD/TRY, WHO, 1991.
10. WHO guidelines for leishmaniasis control at regional and subregional levels (WHO/LEISH/88-25). Geneva:PDP, WHO, 1998.
11. International Development Research Centre (IDRC). Research on control strategies for the leishmaniases: Proceedings of an international workshop, Ottawa, Canada 1-4 June 1987. Leishmaniases: A global problem. Walton, BC. Manuscript Report 184e, 1-5.
12. World Health Organization Report on the consultative meeting on Leishmania/HIV co-infection. WHO/LEISH/95.35, P. 1-14. World Health Organization 1995; Geneva, Switzerland.
13. Dereure J., Reynes J., Pratlong F., et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull. WHO. 73:1995;245-246.
14. Marty P., Le Fichoux Y., Pratlong F., et al. Human visceral leishmaniasis in Alpes-Maritimes. France Epidemiological characteristics for the period 1985-1992 . Trans R Soc Trop Med Hyg. 88:1994;33-34.
15. Pineda J.A., Hernandez-Quero J., Gallardo J.A., et al. Frequency of subclinical visceral leishmaniasis in HIV-infected patients in Spain. Eur J Clin Microbiol Infect Dis. 15:1996;263-264.
16. Al-Gindan Y., Kubba R., El-Hassan A.M., et al. Dissemination in cutaneous leishmaniasis 3. Lymph node involvement . Int J Dermatol. 28:1989;248-253.
17. Kubba R., El-Hassan A.M., Al-Gindan Y., et al. Dissemination in cutaneous leishmaniasis 1. Subcutaneous nodules . Int J Dermatol. 26:1987;300-304.
18. Kubba R., Al-Gindan Y., El-Hassan A.M., et al. Dissemination in cutaneous leishmaniasis 1. Satellite papules and subcutaneous induration . Int J Dermatol. 27:1988;702-706.
19. Haldar J.P., Ghose S., Saha K.C., et al. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun. 42:1983;702-707.
20. Rashid J.R., Chunge C.N., Oster C.N. et al. Post-kala-azar dermal leishmaniasis occurring after long cure of visceral leishmaniasis in Kenya. E Afr Med J. 63:1986;365-371.
21. Rees P.H., Kager P.A. Visceral leishmaniasis and post-kala-azar dermal leishmaniasis. Peters W., Killick-Kendrick R. The leishmaniases in biology and medicine. vol 2:1987;848-907 Academic Press, London.
22. Marsden P.D. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg. 80:1986;859-876.
23. Marsden P.D., Llanos-Cuentos E.A., Lago E.L., et al. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia-Brazil An area of Leishmaniasis braziliensis transmission. III: Mucosal disease, presentation and initial evolution . Rev Soc Bras Med Trop. 17:1984;179-186.
24. Mattos M., Caiza A., Fernandes O., et al. American cutaneous leishmaniasis associated with HIV infection Report of four cases . J Eur Acad Derm Venereol. 10:1998;218-225.
25. De Souza e Souza J., Naiff-Daibes R., Guimaraes T.C., et al. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. J Eur Acad Derm Vererol. 10:1998;214-217.
26. Rosatelli J.B., Souza C.S., Soares F.A., et al. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J Eur Acad Derm Venerol. 10:1998;229-232.
27. Postigo C., Liamas R., Zarco C., et al. Cutaneous lesions in patients with visceral leishmaniasis and HIV infection. J Infect. 35:1997;265-268.
28. Vebra M., Segovia J., Manzano J., et al. Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med. 108:1988;490-491.
29. Romeu J., Sirera C., Ferrandiz C., et al. Visceral leishmaniasis involving lung and cutaneous Kaposi's sarcoma lesion. AIDS. 5:1991;1272.
30. Taiflan B., Marty P., Schneider P., et al. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin. Eur J Med. 1:1992;225.
31. Agostoni C., Dorigoni N., Malfitano A., et al. Mediterranean leishmaniasis in HIV-infected patients Epidemiological, clinical and diagnostic features of 22 cases . Infection. 26:1998;19-25.
32. Perez-Molina J.A., Fortun J., Lopez-Velez R. Anal ulcer and chronic diarrhoea as manifestations of visceral leishmaniasis in a patient infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg. 91:1997;436-437.
33. Miralles E.S., Nunez M., Hilara Y., et al. Mucocutaneous leishmaniasis and HIV. Dermatology. 189:1994;275-277.
34. Berhe N., Hailu A., Gemetchu T. Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to L. aethiopica. Trans R Soc Trop Med Hyg. 89:1995;400-401.
35. Blackwell J.M. Leishmaniasis epidemiology All down to the DNA . Parasitology. 104:(Suppl):1992;S19-S34.
36. Herwaldt B.L., Berman J.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 46:1992;296-306.
37. Berman J.D. Treatment of New World cutaneous and mucosal leishmaniasis. Clin Dermatol. 14:1996;519-522.
38. Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol. 14:1996;513-518.
39. Albanese G., Giorgetti P., Santagostino L., et al. Cutaneous leishmaniasis Treatment with itraconazole . Arch Dermatol. 125:1989;1540-1542.
40. Portu J.P., Santamaria J.M., Zubero Z., et al. Atypical scabies in HIV-positive patients. J Am Acad Dermatol. 34:1996;915-917.
41. Rau R.C., Baird I.M. Crusted scabies in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 15:1986;1058-1059.
42. Hall J.C., Brewer J.H., Appl B.A. Norwegian scabies in a patient with the acquired immune deficiency syndrome. Cutis. 43:1989;325-329.
43. Sirera G., Romeu J., Ribera M., et al. Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies. Lancet. 335:1990;1227.
44. Wishnow Inserra D., Bickley L.K. Crusted scabies in acquired immunodeficiency syndrome. Int J Dermatol. 29:1990;287-289.
45. Donabedian H., Khazan U. Norwegian scabies in a patient with AIDS. Clin Infect Dis. 14:1992;162-164.
46. Glover R., Young L., Goltz R.W. Norwegian scabies in acquired immunodeficiency syndrome Report of a case resulting in death from associated sepsis . J Am Acad Dermatol. 16:1987;396-399.
47. Hulbert T.V., Larsen R.A. Hyperkeratotic (Norwegian) scabies with gram-negative bacteremia as the initial presentation of AIDS. Clin Infect Dis. 14:1992;1164-1165.
48. Sadick N., Kaplan M.H., Pahwa S.G., et al. Unusual features of scabies complicating human T-lymphotropic virus type III infection. J Am Acad Dermatol. 15:1986;482-486.
49. Schlesinger I., Oelrich D.M., Tyring S.K. Crusted (Norwegian) scabies in patients with AIDS The range of clinical presentations . South Med J. 87:1994;352-356.
50. Farrel A.M., Ross J.S., Bunker C.B., et al. Crusted scabies with scalp involvement in HIV-1 infection. Br J Dermatol. 138:1998;188-203.
51. Madsen A. Why Acarus scabiei avoids the face. Acta Derm Venereol (Stockh). 45:1965;167-168.
52. Del Giudice P., Carles M., Gouppie P., et al. Successful treatment of crusted (Norwegian) scabies with ivermectin in two patients with human immunodeficiency virus infection. Br J Dermatol. 135:1996;489-504.
53. Lazaro Ochaita P. Sarna noruega en SIDA. Rev Clin Esp. 193:1993;153-154.
54. O'Donnell B.F., O'Loughlin S., Powell F.C. Management of crusted scabies. Int J Dermatol. 29:1990;258-266.
55. Schultz M.W., Gomez M., Hansen R.C., et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol. 126:1990;167-170.
56. Marby P., Gari-Toussant M., Le Fichoux Y., et al. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol. 88:1994;453.
57. Funkunkhouser M.E., Omohundro C., Ross A., et al. Management of scabies in patients with human immunodeficiency virus disease. Arch Dermatol. 129:1993;911-913.
58. Glaziou P., Cartel J.L., Alzieu P., et al. Comparison of ivermectin and benzyl-benzoate for treatment of scabies. Trop Med Parasitol. 44:1993;331-332.
59. Aubin F., Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med. 332:1995;612.
60. Meinking T.L., Taplin D., Hermida J.L., et al. The treatment of scabies with ivermectin. N Engl J Med. 333:1995;26-30.
61. Greene B.M., Taylor H.R., Cupp E.W., et al. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med. 313:1985;133-138.
62. Macotela-Ruiz E., Pena-Gonzalez G. Tratamiento de la escabiasis con ivermectina por via oral. Gaceta Medica de Mexico. 129:1993;201-205.
63. Hirschman J.V., Chu A.C. Skin lesions with disseminated toxoplasmosis in a patient with acquired immunodeficiency syndrome. Arch Dermatol. 124:1988;1446-1452.